Effects of Etamsylate on Platelet Functions and Arachidonic Acid Metabolism

Summary

The effects of etamsylate on human platelet aggregation and ATP release as well as on the arachidonate metabolism by the platelet have been studied. Etamsylate enhanced these platelet functions induced by arachidonic add (AA), thromboxane A₂, collagen and caldum ionophore A23187 but not those induced by ADP and epinephrine. In experiments with cyclooxygenase-inhibited platelets, AA-induced platelet aggregation was completely inhibited and it was not enhanced by etamsylate, while A23187-induced aggregation was partially inhibited and this aggregation was enhanced by etamsylate. Platelet AA metabolism including thrombin-induced AA liberation from phospholipids as well as the lipoxygenase and cyclo-oxygenase pathways was not significantly affected by etamsylate. These results suggested that etamsylate enhanced platelet response to thromboxane A₂ and calcium ionophore and that this could be included as a mechanism for its potentiating effect on platelet functions.

Keywords

Etamsylate - Platelet function - Arachidonic add metabolism - Thromboxane A₂ - Calcium ionophore

• References

• 1 Jaffe G, Wickham A. A double blind pilot study of Dicynene in the control of menorrhagia. J Int Med Res 1973; 1: 127-129
• 2 Harrison RF, Campbell S. A double-blind trial of ethamsylate in the treatment of primary intrauterine-device menorrhagia. Lancet 1976; 2: 283-285
• 3 Morgan MEI, Benson JWT, Cooke RWI. Ethamsylate reduces the incidence of periventricular haemorrhage in very low birth-weight babies. Lancet 1981; 2: 830-831
• 4 Symes JM, Offen DN, Lyttle JA, Blandy JP, Chaput de Saintongne DM. The effect of Dicynene on blood loss during and after transurethral resection of the prostate. Br J Urol 1975; 47: 203-207
• 5 Reynier J-Pde. L’influence de la prémédication au Dicynone sur le volume de la perte de sang durant l’amygdalectomie. Praxis 1965; 52: 1594-1596
• 6 Raby C, Coupier J. Nouvel hémostatique et antihémorrhagique de synthèse. Hémostase 1965; 5: 389-403
• 7 Deacock AR de, Birley DM. The anti-haemorrhagic activity of ethamsylate (Dicynone). An experimental study. Br J Anaesth 1969; 41: 18-24
• 8 Verstraete M. Report on Ethamsylate. In Haemostatic Drugs. A critical appraisal. Martinus Nijhoff; The Hague, The Netherlands: 1977: 26-37
• 9 Vinazzer H. Clinical and experimental studies on the action of ethamsylate on haemostasis and on platelet functions. Thromb Res 1980; 19: 783-791
• 10 Okuma M, Uchino H. Altered arachidonate metabolism by platelets in patients with myeloproliferative disorders. Blood 1979; 54: 1258-1271
• 11 Okuma M, Takayama H, Uchino H. Subnormal platelet response to thromboxane A₂ in a patient with chronic myeloid leukaemia. Br J Haematol 1982; 51: 469-477
• 12 Takayama H, Okuma M, Uchino H. A simple method for estimation of lipoxygenase and cyclo-oxygenase pathways in human platelets – the use of thiobarbituric add reaction. Thromb Haemostas 1980; 44: 111-114
• 13 Marcus AJ. The role of lipids in platelet function: with particular reference to the arachidonic acid pathway. J Lip Res 1978; 19: 793-826
• 14 Gerrard JM, White JG. Prostaglandins and thromboxanes: “middlemen” modulating platelet function in hemostasis and thrombosis. Prog Hemost Thromb 1978; 4: 87-125
• 15 Detwiler TC, Charo IF, Feinman RD. Evidence that caldum regulates platelet function. Thromb Haemostas 1978; 40: 207-211
• 16 Feinstein MB. Role of Ca²⁺-ions in the regulation of platelet function. Bibl Haematol 1978; 45: 1-8